The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association
Open accessAbstract
A technological solution for the management of diabetes in people who require intensive insulin therapy has been sought for decades. The last 10 years have seen substantial growth in devices that can be integrated into clinical care. Driven by the availability of reliable systems for continuous glucose monitoring, we have entered an era in which insulin delivery through insulin pumps can be modulated based on sensor glucose data. Over the past few years, regulatory approval of the first automated insulin delivery (AID) systems has been granted, and these systems have been adopted into clinical care. Additionally, a community of people living with type 1 diabetes has created its own systems using a do-it-yourself approach by using products commercialized for independent use. With several AID systems in development, some of which are anticipated to be granted regulatory approval in the near future, the joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association has created this consensus report. We provide a review of the current landscape of AID systems, with a particular focus on their safety. We conclude with a series of recommended targeted actions. This is the fourth in a series of reports issued by this working group. The working group was jointly commissioned by the executives of both organizations to write the first statement on insulin pumps, which was published in 2015. The original authoring group was comprised by three nominated members of the American Diabetes Association and three nominated members of the European Association for the Study of Diabetes. Additional authors have been added to the group to increase diversity and range of expertise. Each organization has provided a similar internal review process for each manuscript prior to submission for editorial review by the two journals. Harmonization of editorial and substantial modifications has occurred at both levels. The members of the group have selected the subject of each statement and submitted the selection to both organizations for confirmation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, current algorithms are primarily responsive to immediate glycemic changes and may not fully compensate for delayed carbohydrate absorption, especially from meals rich in fat and protein that can induce delayed hyperglycemia [131, 132, 158].”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [131]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Digital innovations in glucose sensing and insulin delivery have improved glycemic management in diabetes and offer particular advantages in patients with DGP, where delayed and variable carbohydrate absorption leads to erratic glycemic excursions [131, 132].”
From Diabetic gastroparesis: pathophysiology and impact on insulin timing choices (2026) · cites this paper as [131]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Self-citationInternational consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069
Self-citationSix-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
Brown, S. A., Kovatchev, B. P., Raghinaru, D., Lum, J. W., Buckingham, B. A., Kudva, Y. C., Laffel, L. M., Levy, C. J., Pinsker, J. E., Wadwa, R. P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1907863 · Cited by 1,030
Introduction: Standards of Medical Care in Diabetes—2022
American Diabetes Association (2022) · Diabetes Care · doi:10.2337/dc22-sint · Cited by 807
Feig, D. S., Donovan, L. E., Corcoy, R., Murphy, K. E., Amiel, S. A., Hunt, K. F., Asztalos, E., Barrett, J. F. R., Sanchez, J. J., de Leiva, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32400-5 · Cited by 803
Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes
Bergenstal, R. M., Garg, S., Weinzimer, S. A., Buckingham, B. A., Bode, B. W., Tamborlane, W. V., & Kaufman, F. R. (2016) · JAMA · doi:10.1001/jama.2016.11708 · Cited by 644
Self-citationOutpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes
Russell, S. J., El-Khatib, F. H., Sinha, M., Magyar, K. L., McKeon, K., Goergen, L. G., BALLIRO, C. A., HILLARD, M. A., Nathan, D. M., & Damiano, E. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314474 · Cited by 617
Garg, S. K., Weinzimer, S. A., Tamborlane, W. V., Buckingham, B. A., Bode, B. W., Bailey, T. S., Brazg, R. L., Ilany, J., Slover, R. H., Anderson, S. M., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0421 · Cited by 585
Self-citationWEINZIMER, S. A., Steil, G. M., Swan, K. L., Dziura, J., Kurtz, N., & Tamborlane, W. V. (2008) · Diabetes Care · doi:10.2337/dc07-1967 · Cited by 567
The relationships between time in range, hyperglycemia metrics, and HbA1c
Beck, R. W., Bergenstal, R. M., Cheng, P., Kollman, C., Carlson, A. L., Johnson, M. L., & Rodbard, D. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818822496 · Cited by 479
Self-citationWeisman, A., Bai, J.-W., Cardinez, M., Kramer, C. K., & Perkins, B. A. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30167-5 · Cited by 463
Home Use of an Artificial Beta Cell in Type 1 Diabetes
Thabit, H., Tauschmann, M., Allen, J. M., Leelarathna, L., Hartnell, S., Wilinska, M. E., Acerini, C. L., Dellweg, S., Benesch, C., Heinemann, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1509351 · Cited by 450
Self-citationContinuous glucose monitoring and closed‐loop systems
Hovorka, R. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01672.x · Cited by 440
Bekiari, E., Kitsios, K., Thabit, H., Tauschmann, M., Athanasiadou, E., Karagiannis, T., Haidich, A.-B., Hovorka, R., & Tsapas, A. (2018) · BMJ · doi:10.1136/bmj.k1310 · Cited by 437
A Tale of Two Compartments: Interstitial Versus Blood Glucose Monitoring
Cengiz, E., & Tamborlane, W. V. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0002 · Cited by 390
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals
Sims, E. K., Bundy, B. N., Stier, K., Serti, E., Lim, N., Long, S. A., Geyer, S. M., Moran, A., Greenbaum, C. J., Evans-Molina, C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc8980 · Cited by 377
Fleming, G. A., Petrie, J. R., Bergenstal, R. M., Holl, R. W., Peters, A. L., & Heinemann, L. (2020) · Diabetes Care · doi:10.2337/dci19-0062 · Cited by 306
Self-citationNew closed-loop insulin systems
Boughton, C. K., & Hovorka, R. (2021) · Diabetologia · doi:10.1007/s00125-021-05391-w · Cited by 290
Addala, A., Auzanneau, M., Miller, K., Maier, W., Foster, N., Kapellen, T., Walker, A., Rosenbauer, J., Maahs, D. M., & Holl, R. W. (2021) · Diabetes Care · doi:10.2337/dc20-0257 · Cited by 283
Self-citationStandards of Medical Care in Diabetes–2006
Fonseca, V. A., & Clark, N. G. (2006) · Diabetes Care · doi:10.2337/dc06-1150 · Cited by 279
Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes
Stewart, Z. A., Wilinska, M. E., Hartnell, S., Temple, R. C., Rayman, G., Stanley, K. P., Simmons, D., Law, G. R., Scott, E. M., Hovorka, R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602494 · Cited by 279
Regulation of Medical Devices in the United States and European Union
Kramer, D. B., Xu, S., & Kesselheim, A. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmhle1113918 · Cited by 272
Immunotherapy: Building a bridge to a cure for type 1 diabetes
Bluestone, J. A., Buckner, J. H., & Herold, K. C. (2021) · Science · doi:10.1126/science.abh1654 · Cited by 221
Hovorka, R., Elleri, D., Thabit, H., Allen, J. M., Leelarathna, L., El‐Khairi, R., Kumareswaran, K., Caldwell, K., Calhoun, P. M., Kollman, C., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2644 · Cited by 216
Outcome measures for artificial pancreas clinical trials: a consensus report
Maahs, D. M., Buckingham, B. A., Castle, J. R., Cinar, A., Damiano, E. R., Dassau, E., DeVries, J. H., Doyle, F. J., Griffen, S. C., Haidar, A., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2716 · Cited by 211
Self-citationHerman, A., Aerts, O., Baeck, M., Bruze, M., De Block, C., Goossens, A., Hamnerius, N., Huygens, S., Maiter, D., Tennstedt, D., et al. (2017) · Contact Dermatitis · doi:10.1111/cod.12866 · Cited by 192
The development of Biostator, a Glucose Controlled Insulin Infusion System (GCIIS).
Clemens, A. H., Chang, P. H., & Myers, R. W. (1977) · PubMed · Cited by 190
Advanced Diabetes Management Using Artificial Intelligence and Continuous Glucose Monitoring Sensors
Vettoretti, M., Cappon, G., Facchinetti, A., & Sparacino, G. (2020) · Sensors · doi:10.3390/s20143870 · Cited by 176
Stewart, Z. A., Wilinska, M. E., Hartnell, S., O’Neil, L. K., Rayman, G., Scott, E. M., Barnard, K., Farrington, C., Hovorka, R., & Murphy, H. R. (2018) · Diabetes Care · doi:10.2337/dc17-2534 · Cited by 168
Miller, K. M., Beck, R. W., Foster, N. C., Maahs, D. M., & Exchange, F. T. T. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0393 · Cited by 162
Insulin Infusion Set: The Achilles Heel of Continuous Subcutaneous Insulin Infusion
Heinemann, L., & Krinelke, L. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600429 · Cited by 148
Self-citationClosed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial
Thabit, H., Hartnell, S., Allen, J. M., Lake, A., Wilinska, M. E., Ruan, Y., Evans, M. L., Coll, A. P., & Hovorka, R. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30280-7 · Cited by 144
Self-citationImproving the clinical value and utility of CGM systems: issues and recommendations
Petrie, J. R., Peters, A. L., Bergenstal, R. M., Holl, R. W., Fleming, G. A., & Heinemann, L. (2017) · Diabetologia · doi:10.1007/s00125-017-4463-4 · Cited by 143
Self-citationHeinemann, L., Fleming, G. A., Petrie, J. R., Holl, R. W., Bergenstal, R. M., & Peters, A. L. (2015) · Diabetes Care · doi:10.2337/dc15-0168 · Cited by 143
Self-citationClosed-Loop Insulin Delivery During Pregnancy Complicated by Type 1 Diabetes
Murphy, H. R., Elleri, D., Allen, J. M., Harris, J. R., Simmons, D. S., Rayman, G. A., Temple, R., Dunger, D. B., Haidar, A., Nodale, M., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1796 · Cited by 137
Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations
Petrie, J. R., Peters, A. L., Bergenstal, R. M., Holl, R. W., Fleming, G. A., & Heinemann, L. (2017) · Diabetes Care · doi:10.2337/dci17-0043 · Cited by 135
Self-citationData Sharing Under the General Data Protection Regulation
Vlahou, A., Hallinan, D., Apweiler, R., Argilés, À., Beige, J., Benigni, A., Bischoff, R., Black, P. C., Boehm, F., Céraline, J., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16340 · Cited by 134
Braune, K., Lal, R. A., Petruželková, L., Scheiner, G., Winterdijk, P., Schmidt, S., Raimond, L., Hood, K. K., Riddell, M. C., Skinner, T. C., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00267-9 · Cited by 130
Psychosocial impacts of hybrid closed‐loop systems in the management of diabetes: a review
Farrington, C. (2017) · Diabetic Medicine · doi:10.1111/dme.13567 · Cited by 126
Boughton, C. K., Tripyla, A., Hartnell, S., DALY, A. B., Herzig, D., Wilinska, M. E., Czerlau, C., Fry, A. C., Bally, L., & Hovorka, R. (2021) · Nature Medicine · doi:10.1038/s41591-021-01453-z · Cited by 126
Fleming, G. A., Petrie, J. R., Bergenstal, R. M., Holl, R. W., Peters, A. L., & Heinemann, L. (2020) · Diabetologia · doi:10.1007/s00125-019-05034-1 · Cited by 125
Self-citationMurphy, H. R., Kumareswaran, K., Elleri, D., Allen, J. M., Caldwell, K., Biagioni, M., Simmons, D. S., Dunger, D. B., Nodale, M., Wilinska, M. E., et al. (2011) · Diabetes Care · doi:10.2337/dc11-1430 · Cited by 121
Strategies for durable β cell replacement in type 1 diabetes
Brusko, T. M., Russ, H. A., & Stabler, C. L. (2021) · Science · doi:10.1126/science.abh1657 · Cited by 119
Isganaitis, E., Raghinaru, D., Ambler-Osborn, L., Pinsker, J. E., Buckingham, B. A., Wadwa, R. P., Ekhlaspour, L., Kudva, Y. C., Levy, C. J., Forlenza, G. P., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0572 · Cited by 115
The Physiological Rationale for Oral Insulin Administration
Arbit, E. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/1520915041705929 · Cited by 109
Bally, L., Gubler, P., Thabit, H., Hartnell, S., Ruan, Y., Wilinska, M. E., Evans, M. L., Semmo, M., Vogt, B., Coll, A. P., et al. (2019) · Kidney International · doi:10.1016/j.kint.2019.03.006 · Cited by 103
Self-citationTauschmann, M., Allen, J. M., Nagl, K., Fritsch, M., Yong, J., Metcalfe, E., Schaeffer, D., Fichelle, M., Schierloh, U. H. E., Thiele, A. G., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1881 · Cited by 102
A clinical guide to advanced diabetes devices and closed-loop systems using the CARES paradigm
Messer, L. H., Berget, C., & Forlenza, G. P. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0105 · Cited by 100
Feasibility of Continuous Ketone Monitoring in Subcutaneous Tissue Using a Ketone Sensor
Alva, S., CASTORINO, K. N., Cho, H., & Ou, J. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211008185 · Cited by 98
Susceptibility of Interstitial Continuous Glucose Monitor Performance to Sleeping Position
Mensh, B. D., Wisniewski, N. A., Neil, B. M., & Burnett, D. R. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700408 · Cited by 97
Karageorgiou, V., Papaioannou, T., Bellos, I., Alexandraki, K., Tentolouris, N., Stefanadis, C., Chrousos, G. P., & Tousoulis, D. (2018) · Metabolism · doi:10.1016/j.metabol.2018.10.002 · Cited by 93
Home, P. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12501 · Cited by 90
Addala, A., Hanes, S., Naranjo, D., Maahs, D., & Hood, K. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211006476 · Cited by 90
Allergic contact dermatitis caused by glucose sensors in type 1 diabetes patients
Hyry, H., Liippo, J., & Virtanen, H. M. (2019) · Contact Dermatitis · doi:10.1111/cod.13337 · Cited by 87
Heinemann, L., Fleming, G. A., Petrie, J. R., Holl, R. W., Bergenstal, R. M., & Peters, A. L. (2015) · Diabetologia · doi:10.1007/s00125-015-3513-z · Cited by 85
Self-citationKamann, S., Aerts, O., & Heinemann, L. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818762946 · Cited by 85
Self-citationBlauw, H., Onvlee, A. J., Klaassen, M., van Bon, A. C., & DeVries, J. H. (2021) · Diabetes Care · doi:10.2337/dc20-2106 · Cited by 84
Asarani, N. A. M., Reynolds, A. N., Styles, S. E., de Bock, M. I., & Wheeler, B. J. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819870849 · Cited by 81
Adhesives Used for Diabetes Medical Devices: A Neglected Risk With Serious Consequences?
Heinemann, L., & Kamann, S. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816662949 · Cited by 74
Self-citationVigersky, R. A., Velado, K., Zhong, A., Agrawal, P. K., & Cordero, T. L. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0234 · Cited by 61
Cystic fibrosis related diabetes: Medical management
Ode, K. L., Chan, C. L., Granados, A., Moheet, A. A., Moran, A., & Brennan, A. L. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.08.003 · Cited by 59
Rigo, R. S., Levin, L. E., Belsito, D. V., Garzon, M. C., Gandica, R., & Williams, K. M. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820918894 · Cited by 58
Stewart, Z. A., Yamamoto, J. M., Wilinska, M. E., Hartnell, S., Farrington, C., Hovorka, R., & Murphy, H. R. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0060 · Cited by 52
Pleus, S., Ulbrich, S., Zschornack, E., Kamann, S., Haug, C., & Freckmann, G. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0171 · Cited by 47
Glucose Clamps with the Biostator: A Critical Reappraisal
Heinemann, L., & Ampudia‐Blasco, F. J. (1994) · Hormone and Metabolic Research · doi:10.1055/s-2007-1001763 · Cited by 46
Self-citationElleri, D., Allen, J. M., Tauschmann, M., El‐Khairi, R., Benitez‐Aguirre, P., Acerini, C. L., Dunger, D. B., & Hovorka, R. (2014) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2014-000040 · Cited by 43
Herold, K. C., Bucktrout, S. L., Wang, X., Bode, B. W., Gitelman, S. E., Gottlieb, P. A., Hughes, J. W., Joh, T., McGill, J. B., Pettus, J., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126054 · Cited by 43
Practical implementation of automated closed-loop insulin delivery: A French position statement
Tubiana‐Rufi, N., Schaepelynck, P., Franc, S., Chaillous, L., Joubert, M., Renard, É., Reznik, Y., Abettan, C., Bismuth, É., Beltrand, J., et al. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.10.004 · Cited by 42
Self-citationMigdal, A. L., Spanakis, E. K., Galindo, R. J., Davis, G. M., Singh, L. G., Satyarengga, M., Scott, W. H., Fayfman, M., Pasquel, F. J., Albury, B. S., et al. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820930038 · Cited by 40
Allergic contact dermatitis in pediatric patients with type 1 diabetes: An emerging issue
Lombardo, F., Salzano, G., Crisafulli, G., Panasiti, I., Alibrandi, A., Messina, M. F., Pajno, G. B., Caminiti, L., & Passanisi, S. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108089 · Cited by 39
O’Donnell, S., Lewis, D. M., Fernández, M. M., Wäldchen, M., Cleal, B. R., Skinner, T. C., Raile, K., Tappe, A., Ubben, T., Willaing, I., et al. (2019) · JMIR Research Protocols · doi:10.2196/15368 · Cited by 38
Continuous Ketone Monitoring: A New Paradigm for Physiologic Monitoring
Zhang, J. Y., Shang, T., Koliwad, S. K., & Klonoff, D. C. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211009860 · Cited by 38
Oppel, E. M., Kamann, S., Heinemann, L., Reichl, F., & Högg, C. (2019) · Contact Dermatitis · doi:10.1111/cod.13392 · Cited by 37
Self-citationThomas, C., Welsh, J. B., Lu, S., & Gray, J. M. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820920948 · Cited by 37
Herman, A., de Montjoye, L., & Baeck, M. (2020) · Contact Dermatitis · doi:10.1111/cod.13529 · Cited by 36
Self‐reported insulin pump prescribing practices in pediatric type 1 diabetes
Fredette, M. E., Zonfrillo, M. R., Park, S., Quintos, J. B., Gruppuso, P. A., & Topor, L. S. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13213 · Cited by 32
Contact dermatitis caused by glucose sensors in diabetic children
Herman, A., Darrigade, A. ‐., de Montjoye, L., & Baeck, M. (2019) · Contact Dermatitis · doi:10.1111/cod.13429 · Cited by 31
Messer, L. H., Forlenza, G. P., Wadwa, R. P., WEINZIMER, S. A., Sherr, J. L., Hood, K. K., Buckingham, B. A., Slover, R. H., & Maahs, D. M. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12535 · Cited by 30
Self-citationClosed-Loop Insulin Therapy in Older Adults with Type 1 Diabetes: Real-World Data
Toschi, E., Atakov-Castillo, A., Slyne, C., & Munshi, M. N. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0311 · Cited by 30
Palisaitis, E., Fathi, A. E., Oettingen, J. E. V., Haidar, A., & Legault, L. (2020) · Diabetes Care · doi:10.2337/dc20-1232 · Cited by 30
Two Subsequent Pregnancies in a Woman With Type 1 Diabetes: Artificial Pancreas Was a Gamechanger
Schütz-Fuhrmann, I., Schütz, A. K., Eichner, M., & Mader, J. K. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820906219 · Cited by 27
Ruan, Y., Elleri, D., Allen, J. M., Tauschmann, M., Wilinska, M. E., Dunger, D. B., & Hovorka, R. (2014) · Diabetologia · doi:10.1007/s00125-014-3483-6 · Cited by 26
Efficacy of hybrid closed-loop system in adults with type 1 diabetes and gastroparesis
Kaur, H., Schneider, N., Pyle, L., Campbell, K., Akturk, H. K., & Shah, V. N. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0254 · Cited by 24
Prescribing unapproved medical devices? The case of DIY artificial pancreas systems
Roberts, J. T. F., Moore, V. L., & Quigley, M. (2021) · Medical Law International · doi:10.1177/0968533221997510 · Cited by 24
FreeStyle Libre: contact irritation versus contact allergy
Aerts, O., Herman, A., Bruze, M., Goossens, A., & Mowitz, M. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32142-6 · Cited by 24
Aktürk, H. K., Snell‐Bergeon, J. K., & Shah, V. N. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0320 · Cited by 23
Litchman, M. L., Walker, H., Fitzgerald, C., Hoyos, M. G., Lewis, D. M., & Gee, P. M. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820932928 · Cited by 21
Pinsker, J. E., Bartee, A., Katz, M., Lalonde, A., Jones, R., Dassau, E., & Wolpert, H. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0619 · Cited by 21
The artificial endocrine pancreas in clinical research.
Ef, P., Beishcher, W., & Kerner, W. (1977) · PubMed · Cited by 21
Heinemann, L., & Lange, K. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819889641 · Cited by 19
Self-citationBally, L., Herzig, D., Ruan, Y., Wilinska, M. E., Semmo, M., Vogt, A. P., Wertli, M. M., Vogt, B., Stettler, C., & Hovorka, R. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13861 · Cited by 17
Braune, K., May, A., & Thurm, U. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819884922 · Cited by 17
Murray, J. A., Clayton, M. F., & Litchman, M. L. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819895567 · Cited by 17
Freckmann, G., Buck, S., Waldenmaier, D., Zschornack, E., Link, M., Jendrike, N. R. M., Obstfelder, I., Vetrugno, S., Kamann, S., & Haug, C. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820911105 · Cited by 17
Standardized Hybrid Closed-Loop System Reporting
Shah, V. N., & Garg, S. K. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0622 · Cited by 14
Effect of portal glucose sensing on incretin hormone secretion in a canine model
Edgerton, D. S., Kraft, G., Smith, M. S., Moore, L. M., Farmer, B., Scott, M. F., Moore, M. C., Nauck, M. A., & Cherrington, A. D. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00100.2019 · Cited by 12
Feig, D. S., Donovan, L., Corcoy, R., et al. (2018) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000542359.79329.36 · Cited by 7
Blauw, H., Onvlee, A. J., Klaassen, M., van Bon, A. C., & DeVries, J. H. (2021) · doi:10.2337/figshare.13283912 · Cited by 5
Hood, K. K. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819895292 · Cited by 3
Heinemann, L., & Lange, K. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820983948 · Cited by 2
Self-citationCorrection to: New closed-loop insulin systems
Boughton, C. K., & Hovorka, R. (2021) · Diabetologia · doi:10.1007/s00125-021-05443-1
Palisaitis, E., Fathi, A. E., Oettingen, J. V., Haidar, A., & Legault, L. (2020) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2020.08.015
MIGDAL, A., SPANAKIS, E., GALINDO, R. J., DAVIS, G., SINGH, L. G., SATYARENGGA, M., FAYFMAN, M., PASQUEL, F. J., ALBURY, B. S., URRUTIA, M. A., et al. (2020) · Diabetes · doi:10.2337/db20-849-p
PINSKER, J. E., BARTEE, A., KATZ, M., LALONDE, A., JONES, R., DASSAU, E., & WOLPERT, H. (2020) · Diabetes · doi:10.2337/db20-391-p
Closed-Loop Insulin Delivery During Pregnancy in Women With Type 1 Diabetes
Stewart, Z. A., Wilinska, M. E., Hartnell, S., et al. (2017) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000512023.51366.e2
TOSCHI, E., SLYNE, C., ATAKOV-CASTILLO, A., & MUNSHI, M. (2021) · Diabetes · doi:10.2337/db21-147-or
Boughton, C. K., Tripyla, A., Hartnell, S., Daly, A., Herzig, D., Wilinska, M. E., Czerlau, C., Fry, A., Bally, L., & Hovorka, R. (2021) · Nature Medicine · doi:10.1038/s41591-021-01504-5
O'Donnell, S., Lewis, D., Fernández, M. M., Wäldchen, M., Cleal, B., Skinner, T., Raile, K., Tappe, A., Ubben, T., Willaing, I., et al. (2019) · doi:10.2196/preprints.15368
Cited by
Sorted by citations
Sherr, J. L., Laffel, L. M., Liu, J., Wolf, W. A., Bispham, J. A., CHAPMAN, K. S. M., Finan, D. A., Titievsky, L., Liu, T., Hagan, K. A., et al. (2024) · Diabetes Care · doi:10.2337/dc23-1765 · Cited by 105
Self-citationNew advances in type 1 diabetes
Subramanian, S., Khan, F. N., & Hirsch, I. B. (2024) · BMJ · doi:10.1136/bmj-2023-075681 · Cited by 105
MCVEAN, J. J. F., Forlenza, G. P., Beck, R. W., Bauza, C., Bailey, R. J., Buckingham, B. A., DiMeglio, L. A., Sherr, J. L., Clements, M., Neyman, A., et al. (2023) · JAMA · doi:10.1001/jama.2023.2063 · Cited by 90
Self-citationRoos, T., Hermanns, N., Groß, C., Kulzer, B., Haak, T., & Ehrmann, D. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102852 · Cited by 56
Trends and Disparities in Technology Use and Glycemic Control in Type 1 Diabetes
Fang, M., Xu, Y., Ballew, S. H., Coresh, J., Echouffo-Tcheugui, J. B., Selvin, E., & Shin, J. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.26353 · Cited by 45
Metadata
- Authors
- Sherr, J. L., Heinemann, L., Fleming, G. A., Bergenstal, R. M., Bruttomesso, D., Hanaire, H., Holl, R. W., Petrie, J. R., Peters, A. L., & Evans, M.
- Affiliations
- Yale University (US)
- 2Science & Co, Kaarst, Germany
- 3Kinexum, Harpers Ferry, WV
- HealthPartners (US)
- University of Padua (IT)
- Centre Hospitalier Universitaire de Toulouse (FR)
- Universität Ulm (DE)
- University of Glasgow (GB)
- University of Southern California (US)
- University of Cambridge (GB)
- Corresponding author
- Evans, Mark
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2022-10-06
- Volume
- 45
- Issue
- 12
- Pages
- 3058-3074
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4302759931
- Cited by
- 136
- References
- 97
- Citations by year
- 2026: 45 · 2025: 42 · 2024: 31 · 2023: 16 · 2022: 2
- FWCI
- 16.87
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- European Association for the Study of Diabetes
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- artificial pancreas, type 1 diabetes, continuous glucose monitoring, insulin pump, intensive insulin therapy, device safety, regulatory approval, diabetes technology
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Type 1, Glucose, Humans, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Technology, Blood Glucose Self-Monitoring, Consensus, Insulin, Regular, Human
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
